To determine the overall objective response rate of pegylated liposomal doxorubicin
（Lipo-Dox）combined with cyclophosphamide/5-FU as second-line treatment in patients with
metastatic breast cancer.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01451580
Ages eligible for Study
20 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
histologically proved breast cancer with metastatic disease
life expectancy less than 3 months.
All locations for NCT01451580
Put me in touch!
View full eligibility
Tris trial is registered with FDA with number: NCT01451580. The sponsor of the trial is TTY Biopharm and it is looking for 47 volunteers for the current phase.
Official trial title: A Phase II Study of Pegylated Liposomal Doxorubicin (Lipo-Dox) Combined With Cyclophosphamide /5-Fluorouracil as Second Line Chemotherapy in the Treatment of Metastatic Breast Cancer
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.